Royalty Report: Drugs, Assay, Disease – Collection: 233436

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Assay
  • Disease
  • DNA
  • Therapeutic
  • Diagnostic
  • Environmental Control
  • Food
  • Test/Monitoring

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 233436

License Grant
This amendment incorporates changes for expanding the field of use.

With this amendment, Licensee may only resell the Product under Licensees label or a joint Licensee / Licensees distributor label and only as a component of products manufactured by Licensee (and only Licensee) which incorporate both the Product and Licensees proprietary Hybrid Capture system for use in human in vitro diagnostics; pharmaceutical therapeutics research and development; or pharmaceutical screening. In the event that during the term of this Agreement, Licensee develops one or more products for the non-human diagnostic markets such as food and environmental testing, and can demonstrate to Licensor reasonable satisfaction that commencement of commercial sales is imminent, at Licensees request the parties will negotiate in good faith a Reseller Agreement for the Product for use in such Licensee products for the non-human diagnostic markets.

The original agreement was non-exclusive.

License Property
The product is 0.4 mM CDP-Star, with 1 gram/liter of Emerald II Enhancer in aqueous buffer.

Licensors proprietary Hybrid Capture Infectious Disease tests each incorporates the Product for use in human in vitro diagnostics.

The Test shall mean a single DNA probe assay utilizing Product, regardless of use for duplicates, standards or controls, manufactured and/or sold by Licensee.

Field of Use
With this amendment, pharmaceutical screening is added to the field.  The agreement is for use in human in vitro diagnostics or for pharmaceutical therapeutics research and development,  or pharmaceutical screening.

IPSCIO Record ID: 233435

License Grant
The parties desire that the Licensor product shall be purchased by Licensee and that Licensee shall resell the Product, all upon the term.

Licensor appoints Licensee / Reseller as its nonexclusive reseller for the sale, distribution and promotion of the Product.

Licensee may only resell the Product under s label Licensee or a joint Licensee/Licensees distributor label and only as a component of products manufactured by Licensee, and only Licensee, which incorporate both the Product and Licensees proprietary Hybrid Capture system.

Licensor grants to Licensee a non-exclusive right to use the trademarks; marks, trade names and logos that Licensor may adopt from time to time with respect to the Product in connection with Licensees sale and distribution of Product.

In the event Licensor is unable to supply Product to Licensee and such failure to supply continues for a period of six consecutive (6) months. thereafter Licensor will grant Licensee a non-exclusive license under Licensor appropriate patents and know-how to enable Licensee to manufacture such Product solely to the extent necessary to enable Licensee to substitute itself for Licensor as a source of supply for the Product Licensor is unable to supply to Licensee.

License Property
The product is 0.4 mM CDP-Star, with 1 gram/liter of Emerald II Enhancer in aqueous buffer.

Licensors proprietary Hybrid Capture Infectious Disease tests each incorporates the Product for use in human in vitro diagnostics.

The Test shall mean a single DNA probe assay utilizing Product, regardless of use for duplicates, standards or controls, manufactured and/or sold by Licensee.

Field of Use
The agreement is for use in human in vitro diagnostics or for pharmaceutical therapeutics research and development.

IPSCIO Record ID: 237261

License Grant
With this amended and restated agreement, Licensee desires a non-exclusive license under the patent applications, and patents that may issue therefrom, to develop and perform Assays and market Kits in one or more fields.

Licensor grants a non-exclusive immunity from suit in the Territory under Licensor Patent Rights
– to itself perform Licensed Assays;
– to make, have made, use, sell and promote Licensed Kits, and to pass on to end-user purchasers the right to use those Licensed Kits in the Licensed Fields under PHRI Patent Rights; and,
– to develop Licensed Assays and Licensed Kits, and to test Licensed Kits for quality control.

License Property
The licensed property is improvements in fluorescently labeled nucleic acid detection probes, and kits and assays employing such probes.  The patents include but are not limited to Hybridization Probes for Nucleic Acid Detection, Universal Stems, Methods and Kits, and, Detectably Labeled Dual Conformation Oligonucleotide Probes, Assays and Kits, and, Nucleic Acid Detection Probes Having Non-FRET Fluorescence Quenching and Kits and Assays Including Such Probes, and, Non-competitive Co-Amplification Methods, and, Wavelength-Shifting Probes and Primers and Their Use In Assays and Kits, and, Assays for short sequence Variants.
Field of Use
Licensed Fields shall mean the fields of Human In Vitro Diagnostics, Food Testing, and Environmental Testing.

Human In Vitro Diagnostics ( HIVD) shall mean the field of use comprising the in vitro measurement, observation or determination of one or more protein or nucleic acid targets in a sample obtained from a human being for medical management of that human being or for blood banking, bone marrow banking or similar banking of human tissues for human medical management, and pre-clinical uses and clinical trials for the foregoing uses, even if kits for such purposes are labeled Research Use Only or Investigational Use Only.

Food Testing shall mean the field of use comprising the in vitro measurement, observation, or determination of one or more protein or nucleic acid targets of an organism in a sample obtained from food and/or sources of food intended for human consumption in order to determine whether or not that food is fit for consumption.

Environmental Testing shall mean the field of use comprising the in vitro measurement, observation or determination of one or more protein or nucleic acid targets of microorganisms (including bacteria, yeast, viruses and parasites) for the purpose of detecting and/or monitoring environmental contamination in (a) materials associated with a manufacturing process, excluding samples of food intended for consumption, or (b) samples collected from air, soil, water or other liquids, particles or surfaces. Environmental Testing includes testing for the presence of microbiological agents used for bioterrorism and biowarfare.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.